Company Filing History:
Years Active: 2002-2004
Title: The Innovative Contributions of Jacqueline Walling
Introduction
Jacqueline Walling is a notable inventor based in Burlingame, CA (US). She has made significant contributions to the field of medicine, particularly in the development of combination therapies for treating proliferative disorders. With a total of 2 patents, her work is recognized for its potential impact on cancer treatment.
Latest Patents
Walling's latest patents include innovative therapies that utilize pentafluorobenzenesulfonamides. The first patent focuses on a combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents, such as gemcitabine or paclitaxel. This therapy aims to enhance treatment efficacy for patients suffering from proliferative disorders. The second patent also revolves around combination therapies, specifically using pentafluorobenzenesulfonamides in conjunction with antineoplastic platinum coordination complexes like cisplatin. These advancements highlight her commitment to improving therapeutic options in oncology.
Career Highlights
Jacqueline Walling has established herself as a key figure in her field through her innovative research and development efforts. Her work at Tularik Limited has allowed her to collaborate with other talented professionals and contribute to groundbreaking medical advancements.
Collaborations
Walling has worked alongside esteemed colleagues, including Susan Schwendner and Pieter Timmermans. These collaborations have fostered an environment of innovation and creativity, further enhancing the impact of her work.
Conclusion
Jacqueline Walling's contributions to the field of medicine through her patents and collaborative efforts exemplify her dedication to advancing cancer treatment. Her innovative approaches continue to inspire and pave the way for future research in combination therapies.